Overview
Lobbying Costs
9,999€
Financial year: Jan 2019 - Dec 2019
Lobbyists (Full time equivalent)
0.25 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Theravance Biopharma, Inc. (TBPH)
EU Transparency Register
758052539723-25 First registered on 25 Sep 2020
Goals / Remit
TBPH is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialisation of organ-selective medicines. TBPH's purpose is to create transformational medicines to improve the lives of patients suffering from serious illnesses. Its research is focused in the areas of inflammation and immunology.
Main EU files targeted
R&D, COVID-19 therapeutics, regulatory approval of COVID-19 therapeutics, manufacturing, pharmaceutical policies.
Address
Head Office
Connaught House
1 Burlington Road
Dublin Do4 C5Y6
IRELAND -
People
Total lobbyists declared
1
Employment time Lobbyists 25% 1 Lobbyists (Full time equivalent)
0.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
a small number of colleagues outside of Europe may spend a small percentage (10%) of their time on activities related to the register.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
None declared
Member organisations
None declared
-
Financial Data
Closed financial year
Jan 2019 - Dec 2019
Lobbying costs for closed financial year
9,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
None foreseen.
Other activities
None declared
Meetings
Meetings
None declared